Bill · H.R. 7877· House(119-HR-7877)
Shane DiGiovanna Act
- Introduced
- 3/9/2026
- Last activity
- 3/17/2026 — Sponsor introductory remarks on measure. (CR H2535)
- Sponsored by
- Greg Landsman
- Cosponsors
- - 5 - 0
- Introduced
What this bill would do
This bill, known as the "Shane DiGiovanna Act," requires the Secretary of Health and Human Services to create a 2-year demonstration program. This program tests mandatory coverage for epidermolysis bullosa wound care treatment under the Medicaid program. The coverage would include specific items such as antihistamines, acetaminophen, and various wound care supplies. This demonstration would be conducted on a nationwide basis. Finally, the Secretary must submit a report to Congress evaluating the program's effect on expenditures, health outcomes, and hospitalizations.
Yes· 3 of 6
Would people with disabilities be better off under this?+7
The bill ensures essential treatment and wound care supplies are covered for individuals with epidermolysis bullosa.
Does this make health care easier to get in general?+7
The bill expands access to essential wound care supplies and medications for people with epidermolysis bullosa through Medicaid.
Does this expand the rights of people with disabilities?+6
The bill provides mandatory coverage for essential medical treatments required for people living with the disability of epidermolysis bullosa.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Mandatory Coverage of Treatment: The bill requires that specific items and services for treating epidermolysis bullosa be included as medical assistance under Medicaid (Section 2(a)). This could provide essential care for individuals described in section 1902(a)(10)(A)(i) of the Social Security Act.
-
Access to Specific Medical Supplies: The program covers several necessary items (Section 2(b)), including:
- Over-the-counter antihistamines.
- Acetaminophen and nonsteroidal anti-inflammatory drugs.
- Antiseptics and zinc oxide.
- Antibiotic ointments.
- Wound care supplies such as dressings, gauze, and bandage retainers.
Potential Negative Impacts for People
- No negative impacts are explicitly stated in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For People With Disabilities+7Good For Low Income Households+5
- Healthcare
- Improves Healthcare Access+7Increases Medicaid Funding+5
- Social Issues And Justice
- Improves Disability Rights+6Improves Poverty Reduction+3
- 4/2/2026
- 1 Cosponsor added.
- 3/18/2026
- 1 Cosponsor added.
- 3/17/2026
- Sponsor introductory remarks on measure. (CR H2535)
- 2 Cosponsors added.
- 3/16/2026
- 1 Cosponsor added.
- 3/9/2026
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
Debbie DingellDemocrat · Michigan
Josh GottheimerDemocrat · New Jersey
Nancy PelosiDemocrat · California
Brad ShermanDemocrat · California
Bradley SchneiderDemocrat · Illinois